Jan 7, 2026 3-5pm ET
Wednesday on The Robert Scott Bell Show:
Hour 1
Will America’s Dietary Guidelines Lose Their Scientific Backbone? The article raises concern that the forthcoming 2025–2030 Dietary Guidelines for Americans (DGAs) risk departing from rigorous, evidence-based science in favor of policy shifts that could weaken the scientific credibility of national nutrition guidance, arguing that early reports suggest controversial changes — such as dropping longstanding limits on saturated fat intake — may not be grounded in the full body of high-quality research and could have unintended health consequences if adopted without sufficient scientific scrutiny. Traditionally, DGAs rely on systematic review processes conducted by the Dietary Guidelines Advisory Committee, which examines current nutrition science and provides evidence-based recommendations for the U.S. Departments of Health and Human Services and Agriculture to use in formulating the official guidelines; this rigorous foundation has underpinned federal nutrition programs, school meal standards, and public health messaging for decades, lending the DGAs their authority. Early signals that saturated fats might no longer be limited — a recommendation long endorsed by major health organizations — illustrate how proposed shifts could break from established consensus and raise questions about the depth of analysis supporting new policy directions, and critics worry that eliminating numeric thresholds without nuanced consideration of specific fatty acid effects may confuse consumers and policy makers about optimal healthy eating patterns. The article emphasizes that policy should not outpace science, noting that passion and well-intentioned goals are no substitute for repeatable, high-quality evidence, and that oversimplifying nutrition guidance or embracing sweeping reforms without robust research could undermine both the clarity and practical usefulness of the DGAs. It also points out that some ultra-processed foods provide essential nutrients and that definitions of diet quality should focus on nutritional content rather than broad categories like processing alone, suggesting that failing to balance simplicity with scientific nuance could erode trust in national dietary recommendations and weaken the guidelines’ role as an objective foundation for public-health nutrition policy.
Special Guest: Katie Migliori
A lifetime of pain, brain fog, and fatigue, among other issues, has often left me feeling hopeless. Doctors called me lazy and depressed, even though I excelled in several areas. One longtime doctor chastised me for not being able to handle stress well in front of his med student, when I really had a very under-medicated thyroid that he did not think to address. A college counselor told me that a difficult course load was doable, just not for me. Not feeling well for so long was scarring, but turning it into an attack on my character broke me in ways I cannot articulate.
It wasn’t until my late thirties that I found someone who would listen to me. He validated the struggles that others chose not to acknowledge and helped me find answers. I cannot tell you how much good that did my heart and how much those answers empowered me. I went from having to nap several times a day, not being able to sleep at night, and struggling to think clearly to climbing mountains, taking once-in-a-lifetime trips, and securing a dream consulting contract. Because when you feel better, you do better. And the world opens up.
I can’t stand the idea of anyone going through any portion of what I did, but I know that many of you are. I hope to be a source of hope, starting with my January 9th-10th, 2026, holistic health and wellness conference in Logan, Utah.
I believe that our bodies are working for us and wellness comes in things like connecting with others, the sun on our face, and prioritizing good sleep. Our creator has given us the things we need to thrive and the world has tainted many of them. I’ll share modalities we can explore when our bodies need a little more help, as well as better product options than we find in mainstream stores.
More Americans May Be Classified as Obese Under New Definition, Study Suggests A recent study suggests that adopting a newly proposed definition of obesity — one that incorporates measures of body composition and metabolic health in addition to body-mass index (BMI) — could lead to a significantly higher proportion of Americans being classified as obese compared with current standards, potentially reframing how clinicians, researchers, and public-health officials understand and address weight-related health risks. Traditional reliance on BMI, which calculates weight relative to height, has long been criticized for failing to distinguish between fat and muscle mass and for misclassifying individuals with healthy body composition as overweight or obese; the new definition, by contrast, prioritizes factors such as visceral adiposity, insulin resistance, inflammation markers, and functional status, aiming to better capture the metabolic disturbances that contribute to cardiometabolic disease risk. According to the study’s findings, recalibrating obesity criteria to include these additional health indicators could raise obesity prevalence estimates by several percentage points across adult age groups, with implications for healthcare planning, resource allocation, and disease prevention strategies. Researchers involved in the work emphasize that the purpose of refining definitions is not merely to label more people but to identify individuals at elevated risk for serious conditions such as type 2 diabetes, heart disease, and stroke earlier and more accurately, enabling more personalized intervention and monitoring. The article notes that incorporating metabolic measures into obesity classification aligns with growing evidence about the heterogeneity of adiposity-related risk — for example, that individuals with similar BMIs can diverge markedly in cardiometabolic health outcomes — and supports a shift toward nuanced assessments that reflect underlying physiological differences rather than a one-size-fits-all metric. Adoption of the new definition could affect public-health surveillance, clinical thresholds for treatment eligibility, and insurance coverage criteria, prompting debate among experts about the balance between sensitivity, specificity, and practical implementation in diverse populations.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we highlight Sticta Pulmonaria (Lungwort) — a remedy Boericke describes as especially valuable in acute catarrhal states, influenza-like conditions, and respiratory irritation, often accompanied by marked head pressure, dry nasal membranes, and rheumatic or inflammatory joint symptoms.
A characteristic feature is the sensation of a cold coming on, with mental dullness, malaise, and localized inflammatory pains.
Download the Information Sheet
Hour 2
Federal Judge Clears Path for AAP Lawsuit Against RFK Jr. Over Vaccine Policy Changes A federal judge has ruled that a coalition of major U.S. medical organizations, led by the American Academy of Pediatrics (AAP), can proceed with a lawsuit challenging recent vaccine policy changes implemented under Health and Human Services Secretary Robert F. Kennedy Jr., rejecting the government’s motion to dismiss and finding that the plaintiffs have shown sufficient legal standing and plausible claims to warrant further court review. The lawsuit, filed in the U.S. District Court for the District of Massachusetts, alleges that Kennedy’s administration unlawfully restructured the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) by firing all 17 existing experts and appointing new members perceived as aligned with skepticism toward certain vaccines, and that the resulting composition of the panel has led to policy decisions that the plaintiffs contend violate the Federal Advisory Committee Act’s requirements for balanced and unbiased advisory committees. Central to the dispute are policy shifts including the overhaul of the childhood vaccine schedule and alterations to COVID-19 and hepatitis B vaccine recommendations, which the medical groups assert were made without proper scientific basis or adherence to established procedural norms and could undermine public-health efforts to prevent vaccine-preventable diseases. Judge Brian Murphy’s decision to allow the case to move forward opens the door for judicial scrutiny of these actions, including potential challenges to the validity of ACIP votes cast since the restructuring and the broader policy changes that have drawn sharp criticism from pediatricians and public-health experts who argue that such unilateral direction creates confusion, erodes trust in immunization guidance, and may conflict with statutory requirements governing federal advisory panels.
Special Guest: Andreas Kalcker
Dr. h.c. Andreas Ludwig Kalcker is a German-born biophysical researcher who has spent much of his life in Spain and now resides in Switzerland. His primary research focuses on the therapeutic application of frequencies and the medical potential of chlorine dioxide (CLO2). Since 2007, he has dedicated significant effort to understanding the electromolecular mechanisms that contribute to the effectiveness of CLO2 in treating various medical conditions, including arthritis. His work has led to advancements in the development of a refined version of chlorine dioxide, known as CDS, which eliminates adverse effects associated with earlier formulations.
In addition to his research, Dr. Kalcker has authored several books, including CDS: Health is Possible and Health Forbidden: Incurable Was Yesterday, both of which highlight his studies and experiences with CLO2. His work has been recognized through multiple patents related to therapeutic applications targeting hypoxia, inflammation, infection, sepsis, and SARS-CoV-2. He has received numerous academic accolades, including an honorary doctorate from the Executive University of the State of Mexico. His influence has extended globally, particularly in Latin America, where he played a crucial role in advocating for the use of CDS, notably during the COVID-19 pandemic in Bolivia.
Despite his achievements, Dr. Kalcker’s work has been met with controversy, primarily due to misunderstandings and misinformation regarding CDS. Critics, including official authorities such as the FDA, have raised concerns about its safety, often conflating it with harmful substances like sodium hypochlorite. However, these claims have been challenged by various scientific studies and supporters who highlight CDS’s medical potential. Dr. Kalcker remains an active figure in the global health community, continuing his research and advocacy efforts through organizations such as COMUSAV, a coalition of over 5,000 medical professionals dedicated to exploring alternative health solutions.
Vaccine Schedule Reduction Criticized by Sen. Cassidy Senator Bill Cassidy sharply criticized proposed reductions to the U.S. childhood vaccine schedule, arguing that altering long-established recommendations could weaken protection against preventable diseases and create confusion among clinicians, families, and insurers, and warning that significant changes merit robust scientific evidence and deliberation before implementation. Cassidy, a physician lawmaker, said that reducing the number of routine immunizations or shifting from universal to individualized decision-making — as contemplated by Health and Human Services and the CDC — departs from decades of evidence supporting early and comprehensive vaccination, and he expressed concern that diminishing schedule clarity could hinder efforts to maintain high vaccination coverage and safeguard herd immunity. He underscored that consistent, universal guidance has historically been central to controlling outbreaks of measles, whooping cough, and other serious infections, and that diverging from consensus-based schedules risks inconsistent uptake and increased susceptibility. Cassidy also highlighted practical implications, such as how insurers determine coverage and how providers counsel families when standard schedules are altered, suggesting that any reforms should be grounded in clear data demonstrating net population health benefit rather than administrative or philosophical preference. The article situates Cassidy’s criticism within broader national debates over vaccine policy, where proponents of schedule revision argue for personalized approaches based on emerging science and parental choice, while opponents emphasize the long track record of success in disease prevention tied to early and comprehensive immunization practices. The debate reflects ongoing tension between evolving public-health strategies and adherence to historical frameworks designed to reduce disease burden and protect vulnerable populations, with Cassidy’s remarks articulating a cautionary stance toward rapid or substantial schedule changes absent compelling evidence.
The Gut Is Not Just Digestive — New Evidence Shows It Actively Controls Brain Function Emerging research increasingly demonstrates that the gut plays a far more active and influential role in regulating brain function and behavior than previously appreciated, with mechanisms involving bidirectional communication along the gut-brain axis — including neural, immune, and metabolic pathways — that shape cognition, mood, and neurological health beyond basic digestion. The article highlights studies showing that the gut microbiome, composed of trillions of bacteria and other microorganisms, produces metabolites, neurotransmitter precursors, and signaling molecules that interact with the vagus nerve and immune system to influence brain circuits tied to stress response, emotion regulation, memory, and even social behavior. For example, certain bacterial species have been linked to modulation of neurotransmitters such as serotonin and gamma-aminobutyric acid (GABA), which are critical to mood and cognitive processing, suggesting that alterations in microbial balance may contribute to anxiety, depression, and neurodevelopmental disorders. Other research referenced shows that gut inflammation and immune activation can affect blood-brain barrier integrity, neuroinflammation, and microglial function, potentially influencing the onset or progression of neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease, and underlines the importance of diet, lifestyle, and early-life microbial exposures in shaping long-term neurological outcomes. The article also discusses how metabolites such as short-chain fatty acids produced by microbial fermentation of dietary fiber can exert systemic anti-inflammatory effects and support neural resilience, while dysbiosis — an imbalance in microbial communities — has been associated with cognitive decline and behavioral abnormalities in animal models. Researchers are exploring therapeutic strategies aimed at modulating the microbiome through targeted probiotics, prebiotics, and dietary interventions to potentially improve mental health and cognitive function, although the article emphasizes that human clinical evidence is still evolving and that causal relationships are complex. Overall, the piece underscores a paradigm shift in understanding the gut not merely as a digestive organ but as a dynamic regulator of brain health, with implications for preventive and therapeutic approaches to neurological and psychiatric conditions.
New Dietary Guidelines Expected to Align With MAHA Priorities The article anticipates that the forthcoming 2025–2030 Dietary Guidelines for Americans — long-term federal nutrition recommendations jointly issued by the U.S. Department of Health and Human Services and the U.S. Department of Agriculture — will reflect significant departures from past editions by emphasizing whole foods, reducing reliance on ultra-processed products, and challenging longstanding scientific consensus on certain nutrient limits in ways that align with the Make America Healthy Again (MAHA) agenda championed by Health and Human Services Secretary Robert F. Kennedy Jr. and his allies. It notes that the release of updated federal guidelines has been delayed into early 2026 but is expected to stress consuming minimally processed foods such as fruits, vegetables, proteins, dairy, and whole grains while recommending limits on added sugars, sodium, and refined carbohydrates — a shift from some past frameworks that critics say were overly influenced by industry and lacked clear public health impact. The anticipated guidance may also reduce emphasis on strict limits for saturated fat — a change Kennedy himself has publicly supported as promoting “common sense” eating patterns focused on nutrient-dense foods rather than nutrient thresholds — despite ongoing debate among nutrition scientists about cardiovascular impacts of saturated fats and evidence supporting reduction for certain populations. MAHA’s broader strategy report has called for reforms to how the dietary guidelines are developed and communicated, including criticizing ultra-processed food prevalence and suggesting federal nutrition policy reshape school meals, SNAP benefits, and food labeling to prioritize food quality and chronic disease prevention. These potential shifts have drawn both support from advocates of food system reform and concern from some experts who fear that departing from established evidence-based processes could generate confusion and undermine trust in official nutrition guidance, even as the new guidance aims to address America’s high rates of obesity and diet-related chronic disease by aligning federal recommendations more closely with MAHA priorities.
EPA Says It Will Propose Drinking Water Limit for Perchlorate After Court Order The U.S. Environmental Protection Agency announced that it will put forward a proposed national drinking water standard to limit perchlorate—a chemical used in rocket fuel, fireworks, and other explosives that can disrupt thyroid function and pose heightened risks to infants and children—after a federal appeals court ruled that the agency must take regulatory action despite asserting that the public health benefits are limited. The EPA’s announcement explains that the agency’s own data indicate perchlorate at levels of health concern is relatively uncommon in U.S. water systems and that regulating it would impose monitoring and compliance costs on the vast majority of roughly 66,000 systems with little corresponding benefit, but legal requirements under the Safe Drinking Water Act and a court mandate now compel the agency to present enforceable limits and direct utilities to test for the contaminant. Perchlorate contamination historically has arisen through industrial and defense-related pollution, with groundwater near some aerospace, manufacturing, and military sites showing elevated levels; because the substance can hinder thyroid hormone production, which is critical for neurological development, health advocates have long pushed for a standard to protect vulnerable populations. The EPA plans to solicit public comment on several potential maximum contaminant level options—such as 20, 40, or 80 parts per billion—and other elements of the rule before finalizing a regulation, prioritizing stakeholder input even as agency officials maintain that benefits may be modest given the noted infrequency of dangerous concentrations. The move represents the latest chapter in a more than decade-long policy dispute over perchlorate regulation, reflecting tensions between judicial directives, scientific risk evaluations, regulatory costs, and public health concerns.
EU Proposes Food Labeling Rules to Warn Consumers About Processed Chicken and Chlorine Treatments The European Union is considering new food-labeling regulations that would require meat products such as chicken to clearly disclose processing methods — including whether poultry has been treated with chlorine or other antimicrobial washes — in an effort to inform consumers about food production practices and potential chemical interventions. Under the proposed framework, labels on imported and domestically produced poultry would need to specify processing steps that go beyond standard butchering, with a focus on distinguishing conventionally washed products from those subjected to additional antimicrobial treatments aimed at reducing bacterial contamination during processing. Advocates of the change argue that greater transparency empowers consumers to make informed choices based on individual preferences or health considerations, while critics contend that such labeling may imply that certain processing methods are inherently unsafe even when scientific assessments by food-safety authorities, including the European Food Safety Authority and similar U.S. agencies such as the FDA and USDA, deem them acceptable and effective at controlling pathogens like salmonella and campylobacter. The discussion reflects broader debates about chemical use in food production, where chlorine rinses and other interventions have become points of contention between regulatory approaches in the EU and the United States; in the U.S., for example, poultry processors commonly use antimicrobial washes, whereas the EU has historically placed greater restrictions on certain treatments. Retailers and industry groups warn that requiring explicit disclosure of processing methods — especially references to chlorine — could mislead consumers or stigmatize scientifically approved safety practices, potentially affecting trade and market dynamics. Proponents counter that labels should do more than state basic nutritional content — they should include meaningful information about how foods are treated during production. The proposed rules are part of a larger EU initiative to modernize food labeling and strengthen consumer rights, and negotiations between member states and industry stakeholders are ongoing as regulatory bodies seek a balance between transparency, science-based standards, and market practicality.
Remember Friends, The Power to Heal is Yours!
